Literature DB >> 15990704

Extraintestinal manifestations of inflammatory bowel disease.

D Urlep1, P Mamula, R Baldassano.   

Abstract

Inflammatory bowel disease (IBD) predominantly affects the gastrointestinal system but it is associated with a large number of extraintestinal manifestations (EIM). These extraintestinal disorders can significantly contribute to morbidity and impair the overall life quality. EIM may be diagnosed before, concurrently with, or after the diagnosis of IBD is made. The precise etiology of EIM remains unknown. It currently is believed that mucosa from the underlying bowel disease may provide associated immune responses for the inflammatory process in the extraintestinal sites. The involvement of autoimmune mechanisms has been suggested when the shared and unique epitopes in the human colon, eye, joint and biliary epithelium were detected. Recently, the presence of long-lived populations of memory lymphocytes has been discovered which arise as a consequence of bowel inflammation and express homing receptors that direct their migration not only to the gut but also to the extraintestinal sites. The most common extraintestinal disorders associated with IBD include dermatologic, ophthalmologic, musculoskeletal and hepatobiliary diseases, although virtually every organ system may be involved. If these disorders can be considered as the real extraintestinal manifestations of IBD or represent just association between different syndromes of autoimmune etiology, is still not clear. It is important to acquire knowledge on these extraintestinal manifestations of Crohn's disease and ulcerative colitis to start the respective treatment early.

Entities:  

Mesh:

Year:  2005        PMID: 15990704

Source DB:  PubMed          Journal:  Minerva Gastroenterol Dietol        ISSN: 1121-421X


  4 in total

Review 1.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

2.  Occurrence of spontaneous periodontal disease in the SAMP1/YitFc murine model of Crohn disease.

Authors:  Davide Pietropaoli; Rita Del Pinto; Daniele Corridoni; Alexander Rodriguez-Palacios; Gabriella Di Stefano; Annalisa Monaco; Aaron Weinberg; Fabio Cominelli
Journal:  J Periodontol       Date:  2014-12       Impact factor: 6.993

3.  Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.

Authors:  Eva Zold; Arpad Nagy; Katalin Devenyi; Margit Zeher; Zsolt Barta
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

4.  Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis.

Authors:  Fabiola Atzeni; Sandro Ardizzone; Luca Bertani; Marco Antivalle; Alberto Batticciotto; Piercarlo Sarzi-Puttini
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.